These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 7549060)
1. HMGCoA reductase inhibitors and omega-3 fatty acids as adjunctive agents in maintenance immunosuppression after solid organ transplantation. Katznelson S; Wilkinson AH Clin Transplant; 1995 Jun; 9(3 Pt 1):197-200. PubMed ID: 7549060 [TBL] [Abstract][Full Text] [Related]
2. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression. Katznelson S; Kobashigawa JA Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577 [TBL] [Abstract][Full Text] [Related]
4. Potential immunologic effects of statins in cancer following transplantation. Fildes JE; Shaw SM; Williams SG; Yonan N Cancer Immunol Immunother; 2009 Mar; 58(3):461-7. PubMed ID: 18523769 [TBL] [Abstract][Full Text] [Related]
5. New directions for induction immunosuppression strategy in solid organ transplantation. Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743 [TBL] [Abstract][Full Text] [Related]
6. The new immunosuppressive era. Lo Monte AI; Ciancio G; Burke G; Roth D; Miller J Ann Ital Chir; 1999; 70(1):1-19. PubMed ID: 10367502 [TBL] [Abstract][Full Text] [Related]
7. Evolving immunosuppressive regimens for lung transplant recipients. Meyer NJ; Bhorade SM Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795 [TBL] [Abstract][Full Text] [Related]
9. Immunobiology of solid organ transplantation. Turvey SE; Wood KJ Int Surg; 1999; 84(4):279-90. PubMed ID: 10667806 [TBL] [Abstract][Full Text] [Related]
10. Dietary omega-3 polyunsaturated fatty acids can inhibit expression of granzyme B, perforin, and cation-independent mannose 6-phosphate/insulin-like growth factor receptor in rat model of small bowel transplant chronic rejection. Kun Z; Haiyun Z; Meng W; Li Ning ; Li Yousheng ; Li Jieshou JPEN J Parenter Enteral Nutr; 2008; 32(1):12-7. PubMed ID: 18165442 [TBL] [Abstract][Full Text] [Related]
12. Modulation of immunosuppression by DNA transfer in transplantation. McDaniel DO J Long Term Eff Med Implants; 2002; 12(2):131-47. PubMed ID: 12463070 [TBL] [Abstract][Full Text] [Related]
13. Effects of omega-3 fatty acids on organ transplantation. Bonis PA; Chung M; Tatsioni A; Sun Y; Kupelnick B; Lichtenstein A; Perrone R; Chew P; DeVine D; Lau J Evid Rep Technol Assess (Summ); 2005 Feb; (115):1-11. PubMed ID: 15810864 [No Abstract] [Full Text] [Related]
14. New evidence for a role of allograft accommodation in long-term tolerance. Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia. Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495 [No Abstract] [Full Text] [Related]
16. Immunosuppression in organ transplantation. Jordan SC; Rosenthal P; Makowka L Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of dyslipidemia]. Cybulska B Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():11-2. PubMed ID: 12621774 [No Abstract] [Full Text] [Related]
18. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates. Dominiczak M Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712 [No Abstract] [Full Text] [Related]